Lithium Ion

Lithium Ion

SCHEMBL31706629

Cc1cc(C(=O)[O-])cc(C2CCCN(C(=O)C3COC3)C2)c1.[Li+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 3/20 0.40
▸ PROKR1 Q8TCW9 9/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD11B1 P28845 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MYC P01106 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL31705264 0.91 HSD11B1 (0.38) GRM5PROKR1ALDH1A1TSHRHSD11B1
SCHEMBL31705001 0.86 PROKR1 (0.41) GRM5PROKR1ALDH1A1TSHR
Lithium Ion SCHEMBL31705499 0.78 NAMPT (0.40) ALDH1A1
SCHEMBL31704500 0.77 ALDH1A1 (0.39) GRM5PROKR1ALDH1A1HSD11B1MAPT
Lithium Ion SCHEMBL31705741 0.71 NAMPT (0.41) ALDH1A1TSHR
Lithium Ion SCHEMBL31706036 0.70 MYC (0.33) GRM5ALDH1A1MYC
Lithium Ion SCHEMBL31705497 0.70 NAMPT (0.39) —
Lithium Ion SCHEMBL31706119 0.70 NAMPT (0.39) —
Lithium Ion SCHEMBL31705507 0.69 NAMPT (0.30) —
SCHEMBL31705199 0.66 NAMPT (0.41) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback